Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes.
Charbonnel
B
B
Clinique d'endocrinologie, Maladies metaboliques et nutrition, Nantes Cedex, France. bernard.charbonnel@univ-nantes.fr
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D045162:Thiazolidinediones / Q000627:therapeutic use*
D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D045162:Thiazolidinediones